Alkermes Management
Management criteria checks 3/4
Alkermes' CEO is Richard Pops, appointed in Sep 2011, has a tenure of 14.25 years. total yearly compensation is $10.13M, comprised of 12% salary and 88% bonuses, including company stock and options. directly owns 0.78% of the company’s shares, worth $36.80M. The average tenure of the management team and the board of directors is 5.6 years and 6.3 years respectively.
Key information
Richard Pops
Chief executive officer
US$10.1m
Total compensation
| CEO salary percentage | 11.99% |
| CEO tenure | 14.3yrs |
| CEO ownership | 0.8% |
| Management average tenure | 5.6yrs |
| Board average tenure | 6.3yrs |
Recent management updates
Recent updates
Alkermes plc Just Recorded A 62% EPS Beat: Here's What Analysts Are Forecasting Next
Oct 31
Alkermes: A More Than Solid Quarter
Jul 30Is There An Opportunity With Alkermes plc's (NASDAQ:ALKS) 48% Undervaluation?
May 31Alkermes plc's (NASDAQ:ALKS) Earnings Are Not Doing Enough For Some Investors
Apr 21Alkermes' Neuroscience Pivot: ALKS 2680 Set To Revolutionize Narcolepsy Treatment
Feb 25Benign Growth For Alkermes plc (NASDAQ:ALKS) Underpins Its Share Price
Jan 16We Think Alkermes (NASDAQ:ALKS) Can Stay On Top Of Its Debt
Dec 17Alkermes: Products Sales, ALKS 2680 Can Still Drive Long-Term Growth
Nov 24Alkermes plc's (NASDAQ:ALKS) Low P/E No Reason For Excitement
Oct 14Is Alkermes (NASDAQ:ALKS) A Risky Investment?
Sep 17
Robust Product Demand And Critical Innovations Set To Propel Growth, Amid Analysts' Concerns And Revenue Diversification Challenges
Proprietary products and strategic sales like the Athlone facility sale signal robust revenue growth and operational efficiency, showing promise for future earnings.Alkermes: Fairly Valued After Post-Earnings Bump
Jul 28Does Alkermes (NASDAQ:ALKS) Deserve A Spot On Your Watchlist?
Jul 26Alkermes plc's (NASDAQ:ALKS) Business And Shares Still Trailing The Industry
Jul 04The Bottom Fishing Club: Alkermes Has Great Value And Safety
May 17Alkermes' (NASDAQ:ALKS) Solid Profits Have Weak Fundamentals
May 08Alkermes: Waking Up Narcolepsy Treatment With Promising Trial Data
Apr 09Does Alkermes (NASDAQ:ALKS) Have A Healthy Balance Sheet?
Apr 08Alkermes: Slimmed-Down Pharma Not A Compelling Growth Story Yet
Jan 26Is Alkermes (NASDAQ:ALKS) Using Too Much Debt?
Nov 01Alkermes' (NASDAQ:ALKS) Earnings May Just Be The Starting Point
Nov 01Is Alkermes (NASDAQ:ALKS) Using Debt Sensibly?
Jul 15There Is A Reason Alkermes plc's (NASDAQ:ALKS) Price Is Undemanding
Jun 07Is Alkermes plc (NASDAQ:ALKS) Trading At A 44% Discount?
Apr 10Does Alkermes (NASDAQ:ALKS) Have A Healthy Balance Sheet?
Mar 20CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2025 | n/a | n/a | US$338m |
| Jun 30 2025 | n/a | n/a | US$348m |
| Mar 31 2025 | n/a | n/a | US$356m |
| Dec 31 2024 | US$10m | US$1m | US$372m |
| Sep 30 2024 | n/a | n/a | US$387m |
| Jun 30 2024 | n/a | n/a | US$386m |
| Mar 31 2024 | n/a | n/a | US$570m |
| Dec 31 2023 | US$9m | US$1m | US$519m |
| Sep 30 2023 | n/a | n/a | US$455m |
| Jun 30 2023 | n/a | n/a | US$300m |
| Mar 31 2023 | n/a | n/a | -US$9m |
| Dec 31 2022 | US$10m | US$1m | -US$33m |
| Sep 30 2022 | n/a | n/a | -US$129m |
| Jun 30 2022 | n/a | n/a | -US$94m |
| Mar 31 2022 | n/a | n/a | -US$62m |
| Dec 31 2021 | US$9m | US$1m | US$76m |
| Sep 30 2021 | n/a | n/a | -US$92m |
| Jun 30 2021 | n/a | n/a | -US$63m |
| Mar 31 2021 | n/a | n/a | -US$95m |
| Dec 31 2020 | US$8m | US$1m | -US$111m |
| Sep 30 2020 | n/a | n/a | -US$74m |
| Jun 30 2020 | n/a | n/a | -US$126m |
| Mar 31 2020 | n/a | n/a | -US$139m |
| Dec 31 2019 | US$15m | US$1m | -US$197m |
| Sep 30 2019 | n/a | n/a | -US$201m |
| Jun 30 2019 | n/a | n/a | -US$183m |
| Mar 31 2019 | n/a | n/a | -US$173m |
| Dec 31 2018 | US$17m | US$1m | -US$139m |
Compensation vs Market: Richard's total compensation ($USD10.13M) is above average for companies of similar size in the US market ($USD6.90M).
Compensation vs Earnings: Richard's compensation has been consistent with company performance over the past year.
CEO
Richard Pops (63 yo)
Mr. Richard F. Pops has been the Chief Executive Officer and Director of Alkermes PLC since September 2011 and its Chairman since September 16, 2011. Mr. Pops was the Founder of Genomics Collaborative, Inc...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 14.3yrs | US$10.13m | 0.78% $ 36.8m | |
| Executive VP | 4.9yrs | US$4.89m | 0.12% $ 5.7m | |
| Executive VP | 9.6yrs | US$4.12m | 0.12% $ 5.9m | |
| Executive VP of Research & Development and Chief Medical Officer | 8.6yrs | US$4.34m | 0.040% $ 1.9m | |
| Senior VP & Chief Commercial Officer | 5.6yrs | US$3.32m | 0.052% $ 2.5m | |
| Chief Financial Officer | less than a year | no data | no data | |
| Interim Principal Accounting Officer & VP of Finance | 1.8yrs | no data | 0.0047% $ 219.9k | |
| Chief Information Officer & Senior VP of IT | 7.7yrs | no data | no data | |
| Senior Vice President of Corporate Affairs & Investor Relations | no data | no data | no data | |
| Senior VP & Chief Human Resources Officer | 5.5yrs | no data | no data | |
| Senior Vice President of Policy & Government Relations | no data | no data | no data | |
| Senior Vice President of Operations and Environment | no data | no data | no data |
Experienced Management: ALKS's management team is seasoned and experienced (5.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 14.3yrs | US$10.13m | 0.78% $ 36.8m | |
| Independent Director | 5yrs | US$483.16k | 0.027% $ 1.3m | |
| Independent Director | 9.6yrs | US$483.16k | 0.019% $ 898.5k | |
| Independent Director | 1.8yrs | US$1.12m | 0.0065% $ 305.2k | |
| Independent Director | 7.8yrs | US$462.14k | 0.063% $ 3.0m | |
| Independent Director | 4.1yrs | US$460.16k | 0.018% $ 830.2k | |
| Lead Independent Director | 6.3yrs | US$525.16k | 0.019% $ 886.7k | |
| Independent Director | 3.6yrs | US$475.16k | 0.014% $ 656.5k | |
| Independent Director | 6.3yrs | US$473.99k | 0.019% $ 886.7k |
Experienced Board: ALKS's board of directors are considered experienced (6.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/24 14:16 |
| End of Day Share Price | 2025/12/24 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Alkermes plc is covered by 36 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Baird |
| Joel Beatty | Baird |
| Luke Herrmann | Baird |